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TObjective: This study was a prospective evaluation of surgical indications and
outcomes for unilateral and bilateral bronchiectasis according to hemodynamic
(functional and morphologic) classification.
Methods: Between January 1998 and January 2004, the morphologic features (cystic
versus cylindric) by chest computed tomography and the hemodynamic features
(perfused versus nonperfused) by lung ventilation/perfusion scan were determined
in 66 patients with bronchiectasis (53 unilateral and 13 bilateral). The indication for
surgical resection in both groups was the presence of localized areas of cystic,
nonperfused bronchiectasis.
Results: In the unilateral bronchiectasis group, there were 28 female and 25 male
patients with an average age of 37.5  3.8 years (range 6-40 years). Pneumonectomy
was performed in 10 cases (8 left and 2 right), and lobectomy or bilobectomy was
performed in 43. In the bilateral group, there were 7 male and 6 female patients with an
average age of 42  5.4 years (range 9-55 years). Pneumonectomy was performed in
2 cases, lobectomy in 5, and bilateral staged lobectomy in 6. There was 1 postoperative
death (1.5%), and morbidity was 18% (12 patients). Four patients required reexploration
for bleeding, 4 had prolonged air leak develop, 3 acquired pulmonary infections, and 1
had localized empyema develop. During a mean follow-up of 52 months (range 24-82
months), 48 patients were considered cured (73%) and 17 had symptomatic improve-
ment (26%). Pseudomonas infection and underlying chronic obstructive airway disease
were poor prognostic factors (P  .05).
Conclusion: The hemodynamic (functional and morphologic) classification provides
an accurate functional classification for bronchiectasis. Its application in determin-
ing the indications and extent of surgical resection is superior to morphologic
classification alone. Curative resection can be achieved in both unilateral and
bilateral bronchiectasis with acceptable morbidity.
Bronchiectasis was first described by Laennec1 as pathologic changes ofabnormal bronchial dilatation with chronic necrotizing infection. Indeveloping countries, bronchiectasis remains a significant problem.2
Medical management of bronchiectasis has reduced the associated morbidity3 ;
however, mortality with conservative treatment still ranges from 19% to 31%.4
Surgical resection has been proposed for bronchiectasis since the end of the
1930s.5 There is a broad consensus concerning the indications for surgical
resection, which is usually reserved for irreversible, localized bronchiectasis.6-8
The role of surgery in mixed or bilateral bronchiectasis is not yet defined,
especially for patients who do not have improvement with medical treatment.
We previously reported that the classification of bronchiectasis according to
hemodynamic (functional and morphologic) features can define more precisely
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serve.9 In this prospective study, we present the surgical
indications and outcomes for unilateral and bilateral
bronchiectasis.
Methods
Sixty-six patients with bronchiectasis were consecutively operated
on at King Khalid University Hospital, Riyadh, Saudi Arabia,
between January 1998 and January 2004. All patients had bron-
chiectasis diagnosed and were receiving medical therapy in the
form of chest physiotherapy and antimicrobial therapy determined
by culture and sensitivity for a mean period of 26.8  5.3 months
(range 2 months–18 years).
Patient Characteristics
There were 34 female and 32 male patients, with an average age of
29.9  10.8 years (range 6-55 years). All patients had chronic
symptoms for a mean period of 3.4 2.9 years (range 1-19 years),
including chronic productive cough in 73% (48 patients), with
sputum quantity expectorated ranging between 60 and 300 mL/d.
Other symptoms included recurrent infections in 47% (31 pa-
tients), hemoptysis in 35% (23 patients), dyspnea on exertion in
29% (19 patients), and unresolved pneumonia in 15% (10 pa-
tients). Severity of hemoptysis ranged from frequent blood-tinged
sputum to massive, life-threatening hemoptysis as great as 800
mL. Twenty-three patients (35%) had a history of associated
pulmonary disease, including pulmonary tuberculosis (TB) in 12
(18%) and chronic obstructive pulmonary disease (COPD) in 11
(17%). The bacteriologic, acid-fast bacilli, and fungal analyses
were obtained either from sputum or by endoscopic bronchoalveo-
lar lavage. Bacterial infection was preoperatively proven in 37
cases (56%): Haemophilus influenzae in 11, Staphylococcus au-
reus in 9, Streptococcus pneumoniae in 7, Pseudomonas aerugi-
nosa in 6, Bacteroides species in 2, and Klebsiella pneumoniae in
2. All patients were studied with posteroanterior and lateral chest
radiography and a high-resolution computerized tomographic
(HRCT) scan to determine the affected areas and their morpho-
logic features. Each bronchiectatic segment was indexed as cystic
or cylindric. Ventilation/perfusion (V˙ /Q˙ ) lung scan was performed
in all patients to determine the hemodynamic features (perfused
versus nonperfused areas).9 The area affected was considered
indicated for surgery when perfusion was less than 10% of the
expected (nonperfused; Table 1). According to computed tomo-
graphic chest and V˙ /Q˙ scans, the disease was unilateral in 53
patients (80%) and bilateral in 13 (20%). In the unilateral group,
there were 28 female and 25 male patients, with an average age of
37.5  3.8 years (range 6-40 years). In the bilateral group, there
were 7 male and 6 female patients, with an average age of 42 5.4
Abbreviations and Acronyms
COPD  chronic obstructive pulmonary disease
HRCT  high-resolution computed tomography
TB  tuberculosis
V˙ /Q˙  ventilation/perfusionyears (range 9-55 years). Cardiopulmonary assessment included
1386 The Journal of Thoracic and Cardiovascular Surgery ● Novblood gas analysis, full pulmonary function tests, and electrocar-
diography. Lung function studies revealed normal forced vital
capacity and 1-second forced expiratory volume in 43 patients
(65%). Eleven patients (17%) had obstructive lung disease, with
the ratio of 1-second forced expiratory volume to forced vital
capacity less than 75%. The remaining 12 patients (18%) had
restrictive lung disease. Bronchoscopic examination with a flexible
bronchoscope or intraoperative rigid bronchoscope was performed
in all cases to exclude obstructive causes, such as tumor or foreign
body, and to determine the segments involved in hemoptysis.
Patients with endobronchial obstruction, active TB, and systemic
disease (eg, cystic fibrosis and primary ciliary dyskinesia) were
excluded from this study.
Our target area for surgical resection according to our hemo-
dynamic classification, which includes combination of morpho-
logic classification (cystic versus cylindric according to HRCT)
and functional classification (perfused versus nonperfused accord-
ing to V˙ /Q˙ scan), was the cystic nonperfused localized bronchiec-
tasis. The V˙ /Q˙ scan was of help when doubtful morphologic areas
of bronchiectasis were noted and there was a question regarding
the need for surgical resection. In such cases, we adopted a policy
of evaluating perfusion. Only if the perfusion percentage was less
than 10% of the expected was surgical resection advised.
Operative Technique
Toilet bronchoscopy was performed routinely preoperatively. Tra-
cheal intubation with a double-lumen tube for single-lung venti-
lation with early isolation was carried out. With the patient in the
lateral decubitus position, a posterolateral thoracotomy was per-
formed. After surgical resection, careful hemostasis was per-
formed, and two chest drains were inserted. All the lung specimens
resected had histopathologic and culture studies, including TB
examinations. Epidural analgesia was routinely used, and respira-
tory physiotherapy, intravenous antibiotic therapy according to
culture and sensitivity, and COPD therapy were initiated immedi-
ately postoperatively.
Follow-up
Patients had a mean follow-up of 52 months (range 24-82 months).
During the follow-up, patients were assessed according to symp-
toms, sputum culture and sensitivity, and radiologic evaluation.
Selected patients underwent chest HRCT.
Statistical Analysis
Data including age, sex, symptoms, type of bronchiectasis, type of
operation, operative morbidity, and mortality were analyzed for
TABLE 1. Perfusion percentages (mean and range) of the
resected lung
Perfusion (% predicted)
Surgical procedure No. Mean Range
Lobectomy 37 5% 2%-6%
Bilobectomy 17 8% 3%-9%
Pneumonectomy 12 9% 5%-10%these 66 patients. The outcome of the operation was classified as
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leading to surgery, “improved,” meaning reduction in the preop-
erative symptoms, or “no change,” meaning the preoperative
symptoms persisted. Clinical data are reported as means with
ranges. The unpaired Student t test and 2 test were used for group
comparisons as appropriate. Prognostic factors including age, sex,
symptoms, predisposing factors (COPD, TB), organism of infec-
tion, and type of operation were studied.
Results
Surgical resection was guided according to chest HRCT and
lung V˙ /Q˙ scan findings. There were 53 patients (80%) with
unilateral bronchiectasis and 13 (20%) with bilateral bron-
chiectasis. Classification of bronchiectasis according to the
hemodynamic (functional and morphologic) classification
showed that in the unilateral group there were 32 patients
with localized cystic nonperfused bronchiectasis affecting
only one lobe, 11 with multisegmental localized cystic
nonperfused bronchiectasis affecting two lobes, and 10 pa-
tients with cystic nonperfused bronchiectasis affecting the
whole lung. Of the 13 patients with bilateral bronchiectasis,
6 patients had multisegmental localized cystic nonperfused
bronchiectasis affecting two lobes bilaterally, 5 patients had
localized cystic nonperfused bronchiectasis affecting one
lobe on one side and scattered cylindric perfused bronchi-
ectasis on the contralateral side, and 2 patients had cystic
nonperfused bronchiectasis affecting the whole lung on one
side and scattered cylindric perfused bronchiectasis on the
contralateral side. In total, the disease was considered lo-
calized in 59 patients (53 unilateral and 6 bilateral) and was
considered mixed (localized cystic nonperfused and scat-
tered cylindric perfused) in 7 patients.
In the unilateral group, curative surgical resection was
carried out in all cases: pneumonectomy was performed in
10 patients (8 left and 2 right), lobectomy in 32, and
bilobectomy in 11. In the bilateral group, curative surgical
resection was performed in 6 patients in the form of bilateral
staged lobectomy. Five patients with localized cystic bron-
chiectasis affecting one lobe on one side and scattered
cylindric bronchiectasis on the contralateral side underwent
lobectomy of the cystic lobe. Two patients with cystic
bronchiectasis affecting the whole lung on one side and
scattered cylindric bronchiectasis on the contralateral side
underwent emergency pneumonectomy (2 left) as a pallia-
tive treatment for massive, life-threatening hemoptysis:
however, previous assessment of these 2 patients had shown
perfusion values of the contralateral lung greater than 90%
of the expected, with no perfusion defect in both cases.
There was 1 postoperative death (1.5%). A patient with
massive hemoptysis with cystic bronchiectasis affecting one
lung and scattered cylindric bronchiectasis on the contralat-
eral side had postoperative pneumonia develop. Morbidity
occurred in 18% of cases (12 patients). Four patients re-
quired reexploration for bleeding, 4 in the lobectomy group
The Journal of Thoracichad prolonged parenchymal air leak (mean of 7 days), 3 had
pulmonary infection, and 1 had localized empyema that
necessitated computed tomography–guided drainage.
During a mean follow-up of 52  9.4 months (range
24-82 months), 48 patients were considered cured (73%)
and 17 had symptomatic improvement (26%). In the unilat-
eral group, 43 of 53 patients were cured (81%) and the
remaining 10 had improvement (19%). Of the 32 patients
who underwent lobectomy, 25 patients were cured (78%).
Of the 11 patients who underwent bilobectomy, 8 patients
were cured (73%). Of the 10 patients with cystic bronchi-
ectasis affecting the whole lung, all were considered cured.
In the bilateral group, 5 of 6 patients who underwent staged
bilobectomy were cured, and the remaining 6 with residual
cylindric bronchiectasis had improvement. Among the 17
patients with postoperative improvement, residual symp-
toms were explained by the presence of associated scattered
cylindric bronchiectasis in 6 cases. Of the remaining 11
patients, 5 had Pseudomonas infection and 6 had associated
COPD. In the improvement group, follow up chest HRCT
was performed at a mean of 1.9 years. No deterioration of
the unresected cylindric bronchiectasis was noted, and all
patients showed no progressive deterioration in symptoms
during follow-up. Pseudomonas infection (1 patient from 6
patients cured) and underlying COPD (4 patients from 11
cured) were poor prognostic factors (P  .05).
Discussion
In developing countries, bronchiectasis is still common and
is a significant major cause of morbidity and mortality.2 As
the disease progresses, physical activities become increas-
ingly limited, patients fail to thrive, and ultimately they
suffer from social deprivation, intrinsic depression, and
respiratory failure. Although antibiotics and postural drain-
age are widely applied in the medical management of the
disease, resection of the involved segment remains the only
treatment modality that can offer a potential cure.10 Proper
treatment of early chest infections during childhood and
improved health awareness may have contributed to the
reduction of the incidence of bronchiectasis in the devel-
oped countries. In our series, a predisposing cause was
identified in 23 patients (35%), predominantly previous TB
infection; however, most cases remained idiopathic. Sec-
ondary bronchiectasis has a different pathology and man-
agement, and attempts to discriminate obstruction or sys-
temic disease should be made in patients with a chronic
productive cough or hemoptysis. We have previously re-
ported the incidence of bronchiectasis with overlooked for-
eign body.11
Chronic productive cough is usually the most common
presenting symptom and should warrant further radiologic
evaluation. Complications of bronchiectasis may be the
presenting symptoms, mainly hemoptysis. HRCT is cur-
and Cardiovascular Surgery ● Volume 130, Number 5 1387
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tasis.12 In view of the general criticism of the traditional
morphologic classification of bronchiectasis as inadequate,2
the addition of functional classification not only reflects the
degree of severity of the disease process but predicts which
type may have a measured respiratory function. Thus this
hemodynamic classification, which includes morphologic
(cystic versus cylindric) and functional features (perfused
versus nonperfused), is useful in selection of cases for
surgical resection, because the question of which area to
resect and which to preserve is defined more precisely,
especially in cases with diffuse or bilateral bronchiectatic
changes, to have maximum improvement in symptoms with
minimal deterioration of lung function and gas ex-
change.9,10 Ashour9 stated that the morphologic features of
bronchiectasis were correlated with angiographic findings;
two types of bronchiectasis were recognized, nonperfused
and perfused. All lungs with cylindric bronchiectatic
changes were found to be perfused, whereas those with
cystic changes were nonperfused. This discrepancy in the
pattern of pulmonary perfusion reflected the difference in
the severity of the disease process. The pulmonary perfusion
was retained in the area of cylindric changes, and this type
therefore was not a primary indication for surgical resection,
with surgery reserved for more damaged territories.9
There is a broad consensus concerning the indications for
surgical resection. Most physicians and surgeons reserve
this treatment for localized bronchiectasis.6-8 Multisegmen-
tal or bilateral bronchiectasis is generally regarded as a
contraindication for surgery.13 Nevertheless, we are con-
fronted with cases of bronchiectasis involving multiple seg-
ments and lobes, with failure of conservative therapy, for
which surgical intervention may be considered. From the
end of the 1970s onward, few thoracic surgeons have sug-
gested that bilateral bronchiectasis is not a contraindication
to resection.5,14-16 This policy was avoided by many phy-
sicians because of high mortality and poor outcome.17
We believe that surgery should be reserved for patients
in whom curative resection can be achieved, and these are
usually cases of localized cystic unilateral bronchiectasis
but can also extend to bilateral localized bronchiectasis or
complete lung destruction in the absence of other diseased
areas, and for patients with good respiratory performance.18
We also have learned that resection of localized cystic
bronchiectasis in the presence of scattered cylindric bron-
chiectasis can improve symptoms and quality of life with
low operative morbidity. Such instances represented only
11% of our patients. Transplantation remains indicated for
diffuse cystic disease with seriously compromised pulmo-
nary function and chronic respiratory failure.19-21
Pneumonectomy was done in 12 patients, predominantly
as expected on the left side because of the anatomy of left
bronchus syndrome.22 Complications usually range between
1388 The Journal of Thoracic and Cardiovascular Surgery ● Nov9.4% and 24.6%.3,6,8,14 We saw an 18% complication rate,
mainly related to bleeding and prolonged air leak, empha-
sizing the need for good hemostasis and careful dissection.
Our study showed the medium-term benefit of surgery in
unilateral and bilateral bronchiectasis as indicated by hemo-
dynamic classification. Forty-eight patients were considered
cured (73%), and 17 had symptomatic improvement (26%).
In our cases of mixed bilateral localized cystic and scattered
cylindric bronchiectasis, all patients had improvement with
low morbidity after resection of the localized cystic areas. In
cases of bilateral cystic bronchiectasis, the role of surgery is
limited to life-threatening complications as a palliative mea-
sure, and such patients should be listed for lung transplan-
tation if respiratory failure occurs.21
Pseudomonas infection and underlying COPD were poor
prognostic factors (P  .05) in our study. Other studies23
have described several prognostic factors that predicted
good operative results, such as a history of pneumonia, no
or minor airway obstruction, absence of sinusitis-rhinitis,
young age at the time of operation, and restricted unilateral
bronchiectasis in the basal segments of the lower lobes.
Fujimoto and colleagues14 showed three variables as signif-
icant prognostic factors: cylindric type of bronchiectasis,
absence of sinusitis, and complete resection of the diseased
parenchyma.
In the 17 patients who had improvement, follow-up chest
HRCT showed no deterioration of the unresected cylindric
bronchiectasis. All 17 showed no progressive deterioration
in symptoms during follow-up.
Combined morphologic and hemodynamic assessment
provides an accurate functional classification for bronchiec-
tasis. This system is superior to morphologic classification
alone in determining the indications and extent of surgical
resection, especially in the presence of scattered bronchiec-
tasis. Curative resection can be achieved in both unilateral
and bilateral localized bronchiectasis, with acceptable mor-
bidity. Selected patients with mixed cystic and scattered
cylindric bronchiectasis may benefit from surgery, with no
deterioration during follow-up. COPD and Pseudomonas
infection are poor prognostic factors.
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Discussion
Dr John R. Benfield (Los Angeles, Calif). Dr Al-Kattan and
colleagues are exemplary for having cared for 66 patients in 6
years with severe bronchiectasis with only a single death, even
though 12 of these patients required pneumonectomy, including 2
who were treated for massive hemoptysis. This is in large part
because of technically sound surgery and good postoperative care
but in part also because these patients were young.
The basic principle of operation for bronchiectasis is to resect
as little lung as one can in a palliative manner. Therefore I think it
is somewhat surprising that 12 patients (18%) underwent pneumo-
nectomy whereas there were no segmentectomies. Dr Al-Kattan,
can you explain or enlarge on that fact?
Dr Al-Kattan. Eleven of our 66 patients had old TB, and we
frequently see complete destruction of one lung in such patients
and usually do not interfere surgically unless they have symptoms.
We have previously described the left bronchus syndrome, in
which the left lung is more destroyed than the right. In 2 patients
The Journal of Thoracicwe had to perform the surgery because of massive hemoptysis, but
in the remaining 10 cases the contralateral lung was clear and there
was severe bronchiectasis in the other lung. I think this was
probably due to a history of TB, and these patients were coming in
with recurrent chest infection and recurrent productive cough for a
long time, which necessitated the surgery.
Dr Benfield. How do you reconcile this with your exclusion
criteria of TB?
Dr Al-Kattan. At the time of surgery, these patients didn’t
have TB. This is quite important. We excluded the patients who
had active TB or were receiving anti-TB treatment, because they
had a different line of management. A few patients had a history
of TB that had been treated in the past. So I think the bronchiec-
tasis represented a sequela of TB but not active TB.
Dr Benfield. What is really new about this report? One thing
that is new, or at least relatively new, is the use of perfusion studies
(V˙ /Q˙ scans) in addition to HRCT to define what needed to be
resected. I support the effort to know as much as you can about
what needs to be resected. In reading the manuscript, however, I
really couldn’t tell how or even whether the information that you
got from the V˙ /Q˙ scans actually changed what you did. How did
the perfusion studies alter what you would have done had the
information available to you been a good bronchogram or a good
HRCT scan?
Dr Al-Kattan. Actually, as you said, in our hemodynamic
study, we noted that all cases of severely cystic bronchiectasis
were nonperfused. So the addition of V˙ /Q˙ scan at that time was
merely supportive. But we find it important in cases of mixed
bronchiectasis, where you have cystic and cylindric bronchiectasis,
and those patients have symptoms. And it’s a difficult decision
whether to actually offer them surgery or not. You know that you
can improve their symptoms, but you also do not want to com-
promise their pulmonary function. So when we know that these
areas are nonperfused, we can go ahead, knowing that this is an
irreversibly damaged lung and that it will not compromise their
pulmonary function postoperatively and probably will sometimes
improve it because of the avoidance of the shunt. So I believe that
the supportive V˙ /Q˙ scan, especially with scattered cylindric bron-
chiectasis, is quite important in making the decision and predicting
the postoperative status after resection.
Dr Benfield. If one adds the number of pneumonectomies,
which was 12, to the number of bilobectomies, which was 27,
about 40% of your patients required significant pulmonary resec-
tions, which would impair lung function in the long term. The fact
that 73% of your patients were cured of bronchiectasis is excellent,
but we also need to have long-term follow-up with regard to
exercise tolerance and lung function. Do you have any information
about that?
Dr Al-Kattan. Actually, no. These patients usually have
poor pulmonary function in comparison with normal. They
usually have good arterial blood gas values, and the 6-minute
walk is usually fairly good. So it’s difficult to compare. But we
have not observed deterioration with respect to oxygen ex-
change after resection, and I think that is because the areas we
removed were actually in nonperfused areas and were actually
adding to the shunt. Of course, when you have more disease,
those patients are not candidates for surgery because they will
not tolerate this, and they are listed for lung transplantation. In
and Cardiovascular Surgery ● Volume 130, Number 5 1389
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suppurative lung disease for transplantation is actually bronchi-
ectasis. We wait until they are in the range of the lung trans-
plantation zone, and then they are put on the waiting list. But I
agree that the more resection you do, the more you should
worry about the pulmonary reserve, and you should compare it
with the outcome.
Dr Benfield. For the people of Saudi Arabia, it would be
good if pediatric care could somehow be improved and if
antibiotics were to be more readily available, to prevent bron-
chiectasis from occurring. Is there reason to hope that that such
favorable change in pediatric care is happening or that it will1390 The Journal of Thoracic and Cardiovascular Surgery ● NovDr Al-Kattan. Prevention is always better than cure. Vaccinations
in Saudi Arabia have been obligatory for probably the last 20 years,
and actually you cannot get a birth certificate until your child is 5
years old and has finished all the vaccinations, just to force the people
to go in for vaccines. Traditionally, bronchiectasis is considered to be
due to childhood infections, such as measles or whooping cough. I
really don’t know if this is completely true, because some affected
children actually have been vaccinated against these diseases and
have had good primary care. So probably there is more than just
incomplete treatment of childhood infection, but at least it is a pre-
ventive measure to give more education to the pediatrician to deal
more seriously with children’s infections.happen in the future? Dr Benfield. Thank you for catching us up to date.ember 2005
